Cardiovascular Risk Reduction and Diabetes Education: What Are We Telling Our Patients?

Abstract

Get full access to this article

View all access options for this article.

References

The Diabetes Control and Complications Trial Research Group . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.

UK Prospective Diabetes Study (UKPDS) Group . Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998; 352:837-853.

Sacco M , Pellegrini F , Roncaglioni MC , Avanzini F , Tognoni G , Nicolucci A. Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients. Diabetes Care. 2003; 26:264-272.

Heart Outcomes Prevention Evaluation (HOPE) Study Investigators . Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE Study and MICRO-HOPE Substudy. Lancet. 2000;355:253-259.

Ebrahim S , Smith GD. Systematic review of randomized controlled trials of multiple risk factor interventions for preventing coronary artery disease. BMJ. 1997;314:1666-1674.

Montori VM. Evidence-based endocrine practice. Endocr Pract. 2003;9: 321-323.

American Diabetes Association . Clinical practice recommendations 2004. Standards of medical care for patients with diabetes mellitus. Diabetes Care. 2004;27(suppl 1):S15-S35.

American Association of Diabetes Educators . Standards for outcomes measurement of diabetes self-management education. Diabetes Educ. 2003;29: 804-816.

Anderson RM , Funnell MM. Theory is the cart, vision is the horse: reflections on research in diabetes patient education. Diabetes Educ. 1999;25:43-51.

10.

Mulhauser I , Berger M. Evidence-based patient information in diabetes. Diabetic Med. 2000;17: 823-829.

11.

Kopp P.

Fit for practice 6.1: What is evidence-based practice?

Nursing Times. 2001;97:47-50.

12.

Stevens R , Coleman R , Adler A , Stratton I , Matthews D , Holman R. UKPDS 66: risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes. Diabetes Care. 2004;27:1: 201-207.

13.

Gami AS , Montori VM , Erwin PJ , Khan MA , Smith SA. Evidence in Diabetes Enquiry System (EVIDENS) Research Group. Systematic review of lipid lowering for primary prevention of coronary heart disease in diabetes. BMJ. 2003;326: 528-529.

14.

Haffner S , Lehto S , Ronnemaa T , Pyorala K , Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229-234.

15.

Mensing C , Boucher J , Cypress M , et al. National standards for diabetes self-management education. Diabetes Care. 2004; 27(suppl 1):S143-S150.

16.

Mulcahy K , Peeples M , Tomky D , Weaver T. National Diabetes Education Outcomes System: application to practice. Diabetes Educ. 2000;26:957-964.

17.

Peeples M , Mulcahy K , Tomky D , Weaver T. The conceptual framework of the National Diabetes Education Outcomes System (NDEOS). Diabetes Educ. 2001;27:547-562.

18.

Montori V , Smith S. Information systems in diabetes: in search of the holy grail in the era of evidence-based diabetes care. Exp Clin Endocrinol Diabetes. 2001;109(suppl 2): 359-372.

19.

Parkin T , Skinnert TC. Discrepancies between patient and professional recall and perception of an outpatient consultation. Diabetes UK. Diabetic Med. 2003;20: 909-914.

20.

Guyatt GH , Montori VM , Devereaux PJ , Schunemann HJ , Bhandari M. Putting patients first: in our practice and in our use of language. ACP J Club. 2004;140: A11-A13.